South Carolina Sci-Tech Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on South Carolina Sci-Tech Wire.

Press releases published on October 13, 2026

Oct. 13, 2026

VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress

Indeterminate GlobeNewswire

Oct. 13, 2026

Freehand Launches Freehand Pay, Expanding AI Teams from Invoice Audit to Payment

Indeterminate GlobeNewswire

Oct. 13, 2026

维泰瑞隆NAMPT激活剂SIR4156的II期FORGE-LM肥胖症试验完成约50%患者入组

Indeterminate GlobeNewswire

Oct. 13, 2026

維泰瑞隆NAMPT啟動劑SIR4156的II期FORGE-LM肥胖症試驗完成約50%患者入組

Indeterminate GlobeNewswire

Oct. 13, 2026

Opus Genetics to Present at the Chardan Annual Healthcare Conference

Indeterminate GlobeNewswire

Oct. 13, 2026

Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156

Indeterminate GlobeNewswire

Oct. 13, 2026

Floating Fleet AI to Debut Agentic Scheduling Workflow at NBAA-BACE 2026

Indeterminate GlobeNewswire

Oct. 13, 2026

HRCI CEO Dr. Amy Dufrane Appointed President of NAHRMA, the North American Human Resource Management Association

Indeterminate GlobeNewswire

Oct. 13, 2026

iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy

Indeterminate GlobeNewswire

Oct. 13, 2026

Xtract One Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call

Indeterminate GlobeNewswire

Oct. 13, 2026

Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

Indeterminate GlobeNewswire

Oct. 13, 2026

Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update

Indeterminate GlobeNewswire

Oct. 13, 2026

Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis

Indeterminate GlobeNewswire

Oct. 13, 2026

Vetty Announces New Leadership Team to Accelerate AI-Driven Transformation of Hiring

Indeterminate GlobeNewswire

Oct. 13, 2026

New Enterprise Adapter Offers a Supported PowerPlan Integration Between PowerPlan and Oracle® Fusion Cloud ERP

Indeterminate GlobeNewswire

Oct. 13, 2026

Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity

Indeterminate GlobeNewswire

Oct. 13, 2026

Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 13, 2026

Foresight Signed a Non-Binding Term Sheet to Acquire 50.01% in a 270MW Capacity European Data Center Development Company

Indeterminate GlobeNewswire

Oct. 13, 2026

BioNTech veröffentlicht Update zur klinischen Phase-2/3-Studie des mRNA-Krebsimmuntherapiekandidaten BNT113 bei HPV16-positivem metastasiertem Kopf- und Halskrebs

Indeterminate GlobeNewswire

Oct. 13, 2026

BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer 

Indeterminate GlobeNewswire